Multi-center Observational Study to Evaluate Epidemiology and Resistance Patterns of Common ICU-Infections (MOSER)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2011 by Indian Society of Critical Care Medicine.
Recruitment status was Not yet recruiting
Recruitment status was Not yet recruiting
Sponsor:
Indian Society of Critical Care Medicine
Information provided by:
Indian Society of Critical Care Medicine
ClinicalTrials.gov Identifier:
NCT01346735
First received: May 2, 2011
Last updated: NA
Last verified: May 2011
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Most literature on ICU infections and the resistant patterns comes from the western literature. This data may not truly reflect the incidence, epidemiology and resistance patterns in developing countries such as India. However, empiric antibiotic therapy is generally initiated using western guidelines. This can potentially lead to inadequate, inappropriate and ineffective empiric antibiotic therapy for ICU infections in the Indian setting. Hence in this multi-center observational study, we seek to:
- To determine the incidence of ICU-related infections (VAP, CAUTI and CRBSI) in India
- To explore the microbiology, resistance and treatment patterns of these infections
| Condition | Intervention |
|---|---|
|
Nosocomial Infections |
Other: No intervention |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Prospective |
| Official Title: | Multi-center Observational Study to Evaluate Epidemiology and Resistance Patterns of Common ICU-Infections (MOSER) |
Further study details as provided by Indian Society of Critical Care Medicine:
| Estimated Enrollment: | 200 |
| Study Start Date: | June 2011 |
| Estimated Study Completion Date: | December 2011 |
| Estimated Primary Completion Date: | November 2011 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
| ICU infections | Other: No intervention |
Eligibility| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Adult ICU patients
Criteria
Inclusion Criteria:
- ICU stay >48 hours
- One of the following infections (VAP, CAUTI or CRBSI)
Exclusion Criteria:
- Index ICU stay < 48 hours
- Re-admissions to the ICU within the same hospitalization
- Age >18 years or <70 years
- Known HIV serology positivity
- Burns
- Solid organ or Bone-marrow transplant
- No ICU-acquired infections (specifically VAP, CAUTI and CRBSI)
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01346735
Contacts
| Contact: Ramesh Venkataraman, MD | 011-91-44-28296517 | ccmramesh@gmail.com |
| Contact: Rajesh Chawla, MD |
Locations
| India | |
| Indian Society of Critical Care Medicine | Not yet recruiting |
| Mumbai, India | |
Sponsors and Collaborators
Indian Society of Critical Care Medicine
More Information
No publications provided
| Responsible Party: | Dr. Ramesh Venkataraman, Indian Society of Critical Care Medicine |
| ClinicalTrials.gov Identifier: | NCT01346735 History of Changes |
| Other Study ID Numbers: | ISCCM1 |
| Study First Received: | May 2, 2011 |
| Last Updated: | May 2, 2011 |
| Health Authority: | India: Indian Society of Critical Care Medicine |
Keywords provided by Indian Society of Critical Care Medicine:
|
Ventilator associated pneumonia Catheter related blood stream infection Catheter associated urinary tract infection ICU-related infections (VAP, CAUTI and CRBSI) India |
Additional relevant MeSH terms:
|
Cross Infection Infection |
ClinicalTrials.gov processed this record on May 23, 2013